![]() 4’-Methyl-5-methyluridine structure
|
Common Name | 4’-Methyl-5-methyluridine | ||
---|---|---|---|---|
CAS Number | 152540-75-5 | Molecular Weight | 272.25 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C11H16N2O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of 4’-Methyl-5-methyluridine4’-Methyl-5-methyluridine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
Name | 1-[5-Deoxy-4-(hydroxymethyl)-α-L-lyxofuranosyl]-5-methyl-2,4(1H,3H)-pyrimidinedione |
---|---|
Synonym | More Synonyms |
Description | 4’-Methyl-5-methyluridine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
---|---|
Related Catalog | |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C11H16N2O6 |
Molecular Weight | 272.25 |
Exact Mass | 272.100830 |
LogP | -0.26 |
Index of Refraction | 1.597 |
2,4(1H,3H)-Pyrimidinedione, 1-[5-deoxy-4-C-(hydroxymethyl)-α-L-lyxofuranosyl]-5-methyl- |
1-[5-Deoxy-4-(hydroxymethyl)-α-L-lyxofuranosyl]-5-methyl-2,4(1H,3H)-pyrimidinedione |